Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Astellas Pharma Inc (OP: ALPMY )

15.95 USD +0.07 (+0.44%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Astellas Pharma Inc

< Previous 1 2 3 Next >
Where Will Pfizer Be in 5 Years?
What's in store for America's biggest pharmaceutical company and its shareholders? 
Tags MYOV ALPMY VTRS
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20) 10X Genomics Inc (NASDAQ: TXG) Avenue Therapeutics ... 
Tags Penny Stocks General GMAB
From Benzinga
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
Will the pharma giant be interested in acquiring a mid-cap partner with a promising treatment for hepatitis B? 
Tags JNJ ARWR Market News
From Motley Fool
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TRIB MEIP Market News
From Benzinga
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags AQST SYBX NVO
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
This morning 1422 companies reached new 52-week highs. Noteworthy Mentions: Tencent Holdings(OTC: TCTZF)was the ... 
Tags TNTRQ LBRMF EONGY
From Benzinga
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags IMV PEN NVCN
From Benzinga
FibroGen's Anemia Drug Goes to FDA for Review
A decision on Roxadustat should arrive by Dec. 20. 
Tags ALPMY AZN FGEN
From Motley Fool
Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye
Seattle Genetics posted eye-popping data from a study of patients given a combination of Padcev and Keytruda. 
Tags ALPMY Market News MRK
From Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET Tuesday, 411 stocks made new 52-week highs. Interesting Highlights: Microsoft(NASDAQ: MSFT)was ... 
Tags AQN GPN BYD
From Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GALT ASND DXCM
From Benzinga
Stocks That Hit 52-Week Highs On Monday
On Monday morning, 192 companies achieved new highs for the year. Areas of Interest: Microsoft(NASDAQ: MSFT)was the ... 
Tags VGI BLU Industrials
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 296 companies made new 52-week highs. Facts of Interest: Johnson & ... 
Tags ITOCY FLT MRGE
From Benzinga
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
At least one of these bets is already looking like a smart move. 
Tags Market News BGNE AZN
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 152 companies set new 52-week highs. Interesting Highlights: Amazon.com(NASDAQ: ... 
Tags AWK SHOP HR
From Benzinga
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ALXN APTO WST
From Benzinga
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags RVNC ARVN MYOK
From Benzinga
Why Adaptimmune Therapeutics Is Jumping 11.5% Today
The clinical-stage company has inked a new deal with a big biopharma. 
Tags ALPMY ADAP Market News
From Motley Fool
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags ANIX HZNP ACST
From Benzinga
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags XOMA M&A KPTI
From Benzinga
A Perspective On Biopharma's Record M&A Run In 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ... 
Tags Media VRTX CRSP
From Benzinga
Seattle Genetics Drug For Difficult-To-Treat Urothelial Cancer Gets Early FDA Nod
Seattle Genetics, Inc. (NASDAQ: SGEN) shares are advancing following an early approval for Padcev, an antibody conjugate therapy it is ... 
Tags Biotech Bank of America ALPMY
From Benzinga
The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NERV SRPT PRTK
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags M&A AGIO CUE
From Benzinga
There’s more upside for biotech even after 24% gains in two months
Seven biotech stocks to consider buying. 
Tags BOLD Opinion ARQL
From MarketWatch
Stocks That Hit 52-Week Highs On Friday
This morning 257 companies set new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week ... 
Tags JPM BIF ITRI
From Benzinga
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags DRNA News FDA
From Benzinga
Here's Why uniQure Is Rallying 13% Today
Investor optimism is surging following recent M&A in gene therapy. 
Tags ALPMY ONCE Market News
From Motley Fool
The Gene Therapy Names Moving On The Audentes Buyout Deal
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD) announced a deal late Monday to be acquired by Japanese pharma company ... 
Tags Top Stories RHHBY ONCE
From Benzinga
PreMarket Prep Recap: Red On The Screen And Looking For More
With a sea of red engulfing the markets Tuesday morning, there was plenty to discuss on thePreMarket Prep Show. When Red Is Not ... 
Tags ALPMY Technicals Long Ideas
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.